90.16
0.18%
0.16
시간 외 거래:
90.16
전일 마감가:
$90.00
열려 있는:
$90
하루 거래량:
409.82K
Relative Volume:
0.96
시가총액:
$2.95B
수익:
$2.29B
순이익/손실:
$91.98M
주가수익비율:
1,288.00
EPS:
0.07
순현금흐름:
$88.47M
1주 성능:
-0.14%
1개월 성능:
-7.43%
6개월 성능:
-6.29%
1년 성능:
-3.78%
아메디시스 Stock (AMED) Company Profile
명칭
Amedisys Inc
전화
(225) 292-2031
주소
3854 AMERICAN WAY, BATON ROUGE, LA
AMED을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
AMED | 90.16 | 2.95B | 2.29B | 91.98M | 88.47M | 0.07 |
HCA | 332.24 | 82.59B | 69.62B | 5.93B | 5.88B | 20.33 |
THC | 147.92 | 14.45B | 20.97B | 3.13B | 2.39B | 4.33 |
DVA | 164.14 | 13.46B | 12.67B | 827.68M | 1.42B | 5.03 |
FMS | 21.98 | 12.90B | 20.87B | 715.19M | 2.10B | 0.8156 |
UHS | 197.61 | 12.89B | 15.42B | 1.03B | 956.84M | 9.53 |
아메디시스 Stock (AMED) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-06-07 | 다운그레이드 | Truist | Buy → Hold |
2023-04-21 | 개시 | Cantor Fitzgerald | Neutral |
2023-03-13 | 개시 | Barclays | Equal Weight |
2022-10-27 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2022-08-02 | 다운그레이드 | UBS | Neutral → Sell |
2022-06-29 | 개시 | Stifel | Hold |
2022-06-21 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-03-01 | 업그레이드 | UBS | Sell → Neutral |
2022-02-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2022-02-25 | 재확인 | Credit Suisse | Outperform |
2022-02-25 | 재확인 | Oppenheimer | Outperform |
2022-02-25 | 재확인 | RBC Capital Mkts | Outperform |
2022-02-25 | 재확인 | Raymond James | Outperform |
2022-02-25 | 재확인 | Truist | Buy |
2021-09-27 | 개시 | SVB Leerink | Mkt Perform |
2021-09-24 | 개시 | UBS | Sell |
2021-09-10 | 개시 | Cowen | Market Perform |
2021-08-10 | 재확인 | The Benchmark Company | Buy |
2021-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-08-20 | 재개 | Barclays | Overweight |
2020-07-30 | 재확인 | The Benchmark Company | Buy |
2020-06-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-05-07 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2020-03-09 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-01-17 | 개시 | Credit Suisse | Outperform |
2019-11-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2019-10-22 | 재개 | Stephens | Equal-Weight |
2019-09-17 | 개시 | Deutsche Bank | Buy |
2019-05-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2018-12-14 | 개시 | Barclays | Equal Weight |
2018-11-16 | 개시 | UBS | Neutral |
2018-10-30 | 업그레이드 | The Benchmark Company | Hold → Buy |
2018-07-03 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2018-03-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
2017-11-09 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2017-11-08 | 재확인 | Mizuho | Buy |
2017-11-02 | 업그레이드 | The Benchmark Company | Hold → Buy |
2017-08-21 | 개시 | BofA/Merrill | Neutral |
모두보기
아메디시스 주식(AMED)의 최신 뉴스
Why the DOJ’s Lawsuit Against the UGH-Amedisys Merger May Not Go Anywhere - MedCity News
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports - MSN
US sues to block UnitedHealth's $3.3 billion purchase of Amedisys - MSN
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys - MSN
Alpine Associates Management Inc. Decreases Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys - MSN
Principal Financial Group Inc. Sells 33,149 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
U.S. Justice Department moves to block big healthcare purchase - Nevada Current
DOJ Challenges UnitedHealth And Amedisys Merger - Evrim Ağacı
ACA subsidy optimism and a fiery antitrust speech - STAT
Amedisys stock touches 52-week low at $89.54 amid market shifts - Investing.com
Inside the Justice Department’s Amedisys-Optum Lawsuit - Hospice News
LMR Partners LLP Reduces Stake in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Amedisys Earnings: An Early Look - AOL
ING Groep NV Cuts Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal - MSN
Justice Department and four Attorneys General block $3.3 billion acquisition of Amedisys Inc. - MSN
DOJ is suing to block UnitedHealth's $3.3 billion purchase of Amedisys - Fortune
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape - AOL
Evaluating The DOJ’s Arguments Against The UnitedHealth Group-Amedisys Deal - Home Health Care News
Justice Department sues to block UnitedHealth Group’s $3.3 billion purchase of Amedisys - Nashua Telegraph
DOJ Sues to Stop UnitedHealth's Amedisys Acquisition - Newser
Juniper Networks falls as DOJ sues to block Amedisys sale to UnitedHealth - MSN
DOJ files lawsuit to block UnitedHealth from purchasing Amedisys - The San Joaquin Valley Sun
DOJ sues to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
DOJ sues to block UnitedHealth’s acquisition of Amedisys - Business Insurance
DOJ sues to block UnitedHealth's acquisition of Amedisys - Healthcare Finance News
$3B Health Care Merger Would Be Bad For New Jersey, Other States: Feds - Patch
New York Attorney General Letitia James joins lawsuit against UnitedHealth Group merger - CNYcentral.com
DOJ prepares lawsuit to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
Justice Department sues to block United Health merger with Amedisys - ConsumerAffairs
UnitedHealth-Amedisys merger targeted by Justice Department - The Business Journals
DOJ sues UnitedHealth/Amedisys to shut down “massive healthcare ecosystem” - Global Competition Review
New York attorney general joins lawsuit to block UnitedHealth, Amedisys merger - MSN
Why UnitedHealth, Amedisys are standing behind their deal - Modern Healthcare
Justice Department Blocks UnitedHealth's Amedisys Acquisition - Evrim Ağacı
아메디시스 (AMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):